ALKBH5 and neoplasm: IHC staining results indicated that the deletion of ALKBH5 significantly increased the number of tumor-infiltrating CD3+, CD4+, and CD8+ T cells (Fig. 2A, B) but not in the FOXP3+ cells (Supplementary Fig. 1H).